4
Changes in Ownership
Avalo Therapeutics, Inc. Filed Acc 0001192482-20-000820
Chief Commercial Officer bought 171 shares at $2.28 ($390)
From the SEC's structured data for this filing
Trades in this filing
Harrell James Archie Jr · Chief Commercial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-12-10 | Purchase : show line 1 in the form | +171 | $2.28 | $390 | 28,180 | D |
| Open-market purchases · 171 sh · avg $2.28 · $390 | ||||||
Loading xslF345X03/edgar.xml…